The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03865550
Recruitment Status : Unknown
Verified March 2019 by Rothman Institute Orthopaedics. Recruitment status was: Active, not recruiting
The purpose of this study is to establish the effect of sub-anesthetic dosing of ketamine with spinal anesthesia during total knee arthroplasty on post-operative pain and narcotic consumption. We hypothesize that sub-anesthetic ketamine will decrease post-operative pain and narcotic consumption and may secondarily lead to shorter lengths of stay, faster rehabilitation, improved postoperative outcomes and patient satisfaction.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
Child, Adult, Older Adult
18 - 85 years of age
ASA I - IV
Undergoing primary unilateral elective total knee arthroplasty with spinal anesthesia
BMI over 40*
Contraindication or allergy to opioid pain medication or ketamine*
Daily opioid use for pain control before surgery in excess of systemic morphine equivalent to 10 mg*
Ejection fraction (EF) less than 30%
Creatinine clearance less than 30 mL/min*
History of chronic liver failure
Desire for nerve block or general anesthesia
Any neurologic or psychiatric disorder (including bipolar disorder, post traumatic stress disorder, schizophrenia)
Prior surgery on ipsilateral knee within the last 6 months